Latest Breaking News On - Prnewswire ratio therapeutics inc - Page 1 : comparemela.com

Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment

Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRachelle babbMey boukennaJohn babichStephen pagliucaJack hoppinRusso partnersSecurities exchangeTechnology licensing at cornell universityPrnewswire ratio therapeutics incRatio therapeutics incBristol myers squibbMore thanTechnology licensingChief executiveSecurities act

Ratio Therapeutics Appoints Dr Noel Monks as Head of Biology

/PRNewswire/ Ratio Therapeutics Inc. (Ratio), a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of.

United statesJohn babichErica fioriniJack hoppinAstrazeneca medimmuneUniversity of newcastle upon tynePrnewswire ratio therapeutics incRatio therapeutics incRusso partnersDrug developmentNoel monksChief scientificSenior directorPreclinical biologyNeubase therapeuticsAssociate director

Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment

/PRNewswire/ Ratio Therapeutics Inc., a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of cancer,.

United statesJohn babichErica fioriniJack hoppinKenan turnaciogluSusank whoriskeyMomenta pharmaceuticalsPrnewswire ratio therapeutics incRusso partnersCompany board of directors as strategic advisorCubist pharmaceuticalsFounding executive teamLantheus holdings incRatio therapeutics incCompany brings total financing to more thanMore than

Ratio Therapeutics Appoints Reed Malleck as Chief Financial Officer

/PRNewswire/ Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class targeted.

United statesJohn babichErica fioriniJack hoppinAsia pacificReed malleckPrnewswire ratio therapeutics incRusso partnersUniversity of coloradoRatio therapeutics incUs armyPolice corpsChief financial officerChief executiveTreasury managerInternal audit manager

Ratio Therapeutics Appoints Jacob Hesterman, Ph D , as Chief Data Officer

/PRNewswire/ Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class targeted.

United statesJacob hestermanJohn babichErica fioriniJack hoppinWorld molecular imaging societyPrnewswire ratio therapeutics incRusso partnersRatio therapeutics incUniversity of arizonaSociety of nuclear medicineTherapeutics incChief data officerChief executiveSenior vice presidentImage analysis